Guruprasad Manjunath is a Nephrology physician. OpenAlex indexes 8 publications with 2,978 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3366 NW Expressway
Suite 550
Oklahoma City, OK 731124462
Telephone
405-942-5442Registry record last updated 3 May 2010.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20253 payments
- Calliditas Therapeutics US Inc.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
70.6%Loop diuretic24.2%Torsemide52%Furosemide48%Part D≥80 patientsCalcium channel blocker20.6%Amlodipine Besylate87%Nifedipine Er13%Part D≥105 patients+ 7 more classes in this area
Metabolism & gastrointestinal
18.5%Potassium supplement8.5%Potassium Chloride100%Part D≥52 patientsSGLT2 inhibitor8%Jardiance100%Part D≥28 patients+ 1 more class in this area
Other
4%Phosphate Binder2.1%Sevelamer Carbonate100%Part D≥14 patientsDrugs for treatment of hyperkalemia and hyperphosphatemia1.9%Velphoro69%Auryxia31%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Level of kidney function as a risk factor for cardiovascular outcomes in the elderly
Kidney International
2003 - Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community
Journal of the American College of Cardiology
2002 - Anemia as a risk factor for cardiovascular disease in the atherosclerosis risk in communities (aric) study
Journal of the American College of Cardiology
2002 - CLINICAL STUDIES Coronary Atherosclerosis Anemia as a Risk Factor for Cardiovascular Disease in the Atherosclerosis Risk in Communities (ARIC) Study2002
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”